Atlas Trials

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

Clinical trial NCT02931071 · COMPLETED

Trial details

NCT number
NCT02931071
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fanconi Anemia
Start date
2013-09-01
Primary completion
2018-10-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.